In Other News

• Cellink Relaunches Real-Time qPCR Instrument for COVID-19

• Novacyt's Two-Hour Coronavirus Test Gains FDA Emergency Use Approval

• Ortho Clinical Diagnostics Releases COVID-19 Antibody Test

• Chembio Launches DPP COVID-19 Serological Point-of-Care Test

• A. Menarini and Credo Diagnostics Enter into Agreement for Distribution of SARS-CoV-2 Assay Kit

• NeuMoDx Secures FDA Emergency Use Authorization for Coronavirus Test

• World’s First Online Image-Based COVID-19 Diagnosis Improvement Tool Launched

• Siemens Healthineers Announces Availability of Molecular Fast Track Diagnostics SARS-CoV-2 Assay Test Kit

• DiaSorin’s COVID-19 Test Receives FDA Emergency Use Authorization

• QIAGEN Receives US FDA EUA for First and Only Syndromic Coronavirus Test

• Carolina Liquid Chemistries Offers COVID-19 Rapid Screen Antibody Test

• Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test

• Beckman Coulter Developing Tests to Detect Coronavirus Antibodies

• Siemens' RAPIDPoint 500e Blood Gas Analyzer Receives US FDA Clearance to Aid in COVID-19 Care

• Quidel’s Lyra SARS-CoV-2 Secures Expanded Use Authorization from US FDA

• Hardy Diagnostics Releases Autobio’s One-Step Test for COVID-19

• University of Oxford Develops Rapid Testing Technology for Coronavirus; Starts Clinical Trial of Potential Drug Treatments

• New Paper-Based Rapid Test for COVID-19 Awaiting FDA EUA Approval

• Chembio and LumiraDx Enter into COVID-19 Strategic Partnership

• PerkinElmer’s New Nucleic Acid Detection Kit for SARS-CoV-2 Secures FDA EUA Approval

• Luminex Receives US FDA Emergency Use Authorization for COVID-19 Virus Detection Test

• The COVID-19 Coronavirus Remains Viable for Hours or Days on Solid Surfaces

• Factors Associated with ARDS in COVID-19 Identified